Dermal Fillers
YVOIRE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11239
Yvoire Y-Solution 360
In stock
Volume
1 x 1 mL
Laboratory
LG Chem
Origin
South Korea
Indication
Anti-ageing correction with flexible projection
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution range. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that provide flexibility, projection and resistance to the dynamics of facial expression. Yvoire 360 filler contains 12 mg/mL of cross-linked hyaluronic acid and is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed. It is CE-marked and intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Contains cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range
- Supplied with two Terumo thin-wall 29G needles, the finest gauge in the YVOIRE range
- CE-marked medical device
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Professional use
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. The injection plane is not stated in the documentation held on file; distributor listings describe superficial to mid-dermal placement, which must be confirmed against the manufacturer's Instructions for Use before use. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is a considerably lighter gel than the Volume and Contour references, so patients seeking structural contouring of the jawline or chin, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patient selection follows the manufacturer's Instructions for Use.
How Yvoire Y-Solution 360 Works
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL, formulated for what the manufacturer describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is a light gel by comparison with the 22 mg/mL Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 720?
Both sit in the same Y-Solution line, share the elasticity and cohesion concept, and contain 0.3% lidocaine. This reference, the 360, is documented at 12 mg/mL cross-linked hyaluronic acid and supplied with 29G needles, making it the lighter of the two. The 720 reference is documented at 20 mg/mL and supplied with 27G needles. Each figure comes from that product's own documentation. The 540 reference sits between them in the range, but its specifications are not covered here.
Which areas can be treated with Yvoire Y-Solution 360?
The manufacturer gives the application zone as the face, and lists anti-ageing aesthetic treatment, facial projection support, and treatments requiring flexibility and cohesion among the indications. Specific treatment zones are not named in the documentation held on file.
Does Yvoire Y-Solution 360 contain lidocaine?
Yes. The documentation specifies 0.3% lidocaine alongside 12 mg/mL of cross-linked hyaluronic acid. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
Which needles are supplied with Yvoire Y-Solution 360?
Two Terumo thin-wall 29G needles are enclosed, alongside a single 1 mL syringe. That is the finest gauge supplied with any YVOIRE reference written so far, compared with 27G for Y-Solution 720 and the Volume products, and 21G or 23G for Contour.
How long do the results of Yvoire Y-Solution 360 last?
No duration is published in the documentation held on file. A peer-reviewed one-year safety evaluation of the YVOIRE Y-Solution series has been published, but that is a safety assessment rather than a manufacturer durability claim .
Is Yvoire Y-Solution 360 CE-marked?
Yes. The documentation states that the product is CE-marked and classifies it as medical. The device class and Notified Body are not published in that documentation .
More from LG Chem
Clinic alternatives
Mesotherapy
Skin Boosters
/ Recently viewed
Pick up where you left off
Yvoire Y-Solution 360
In stock
CE Marked
Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler with 0.3% lidocaine, manufactured in South Korea as part of the YVOIRE Y-Solution range. The manufacturer describes the range as built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that provide flexibility, projection and resistance to the dynamics of facial expression. Yvoire 360 filler contains 12 mg/mL of cross-linked hyaluronic acid and is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed. It is CE-marked and intended for professional use by qualified practitioners only.
Key Benefits of Yvoire Y-Solution 360
- Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides flexible projection and is designed to resist the dynamics of facial expression
- Contains cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine
- Supports anti-ageing aesthetic treatment approaches
- Part of the Y-Solution 360, 540 and 720 range
- Supplied with two Terumo thin-wall 29G needles, the finest gauge in the YVOIRE range
- CE-marked medical device
Indications and Professional Use
Main indications
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring flexibility and cohesion
Professional use
Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. The injection plane is not stated in the documentation held on file; distributor listings describe superficial to mid-dermal placement, which must be confirmed against the manufacturer's Instructions for Use before use. Injection technique and volume per treatment area are determined by the practitioner.
Treatment areas
- Face
Patient profile
Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is a considerably lighter gel than the Volume and Contour references, so patients seeking structural contouring of the jawline or chin, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patient selection follows the manufacturer's Instructions for Use.
How Yvoire Y-Solution 360 Works
Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL, formulated for what the manufacturer describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is a light gel by comparison with the 22 mg/mL Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.
Why Order From Allpara
Allpara offers genuine, verified YVOIRE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 720?
Both sit in the same Y-Solution line, share the elasticity and cohesion concept, and contain 0.3% lidocaine. This reference, the 360, is documented at 12 mg/mL cross-linked hyaluronic acid and supplied with 29G needles, making it the lighter of the two. The 720 reference is documented at 20 mg/mL and supplied with 27G needles. Each figure comes from that product's own documentation. The 540 reference sits between them in the range, but its specifications are not covered here.
Which areas can be treated with Yvoire Y-Solution 360?
The manufacturer gives the application zone as the face, and lists anti-ageing aesthetic treatment, facial projection support, and treatments requiring flexibility and cohesion among the indications. Specific treatment zones are not named in the documentation held on file.
Does Yvoire Y-Solution 360 contain lidocaine?
Yes. The documentation specifies 0.3% lidocaine alongside 12 mg/mL of cross-linked hyaluronic acid. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.
Which needles are supplied with Yvoire Y-Solution 360?
Two Terumo thin-wall 29G needles are enclosed, alongside a single 1 mL syringe. That is the finest gauge supplied with any YVOIRE reference written so far, compared with 27G for Y-Solution 720 and the Volume products, and 21G or 23G for Contour.
How long do the results of Yvoire Y-Solution 360 last?
No duration is published in the documentation held on file. A peer-reviewed one-year safety evaluation of the YVOIRE Y-Solution series has been published, but that is a safety assessment rather than a manufacturer durability claim .
Is Yvoire Y-Solution 360 CE-marked?
Yes. The documentation states that the product is CE-marked and classifies it as medical. The device class and Notified Body are not published in that documentation .
More from LG Chem
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.